The prevalence of altered body image in patients with primary brain tumors: an understudied population.


Journal

Journal of neuro-oncology
ISSN: 1573-7373
Titre abrégé: J Neurooncol
Pays: United States
ID NLM: 8309335

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 09 12 2019
accepted: 12 02 2020
pubmed: 26 2 2020
medline: 3 2 2021
entrez: 26 2 2020
Statut: ppublish

Résumé

Body image (BI) is an important issue for cancer patients, as patients with BI concerns are susceptible to depression, anxiety, difficulty coping, and poor quality of life (QoL). While this concern has been documented in patients with other malignancies, no data exists of this QoL issue in patients with primary brain tumors (PBT). A cross-sectional survey of 100 PBT patients was conducted on an IRB approved prospective protocol using structured questionnaires. Participants completed the body image scale (BIS), Appearance Scheme Inventory Revised (ASI-R), MD Anderson Symptom Inventory Brain Tumor (MDASI-BT), and Patient-Reported Outcomes Measurement Information System (PROMIS) Depression, Anxiety, and Psychosocial Impact Positive measures. The prevalence of clinically significant body image dissatisfaction (BIS ≥ 10) was 28% (95% CI 19-37%), median BIS score was 5 (range 0-27). The median ASI-R composite score was 2.9 (range 1.5-4.7). BIS was significantly correlated with the ASI-R (r = 0.53, 95% CI 0.37 to 0.65). The mean PROMIS Depression score was 48.4 (SD = 8.9), PROMIS Anxiety score was 49.4 (SD = 9.9), and PROMIS Psychosocial Illness Impact Positive score was 48.9 (SD = 9.7). BIS was significantly correlated with age, and trended with BMI and sex. The PROMIS Psychosocial Illness Impact Positive and PROMIS Anxiety scores were the most strongly related to BIS. This study, the first to explore altered body image in PBT patients, revealed clinically significant body image dissatisfaction in nearly 1/3 of patients, similar to other malignancies. These findings underscore the potential contribution of disease and treatment-related body image concerns on psychosocial wellbeing in patients with PBT.

Identifiants

pubmed: 32096067
doi: 10.1007/s11060-020-03433-8
pii: 10.1007/s11060-020-03433-8
pmc: PMC7136178
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

397-404

Subventions

Organisme : NIH Clinical Center
ID : 1ZIABC011768-02

Références

Annunziata MA, Giovannini L, Muzzatti B (2012) Assessing the body image: relevance, application and instruments for oncological settings. Support Care Cancer 20(5):901–907. https://doi.org/10.1007/s00520-011-1339-x
doi: 10.1007/s00520-011-1339-x pubmed: 22160547
White CA (2000) Body image dimensions and cancer: a heuristic cognitive behavioural model. Psychooncology 9(3):183–192
doi: 10.1002/1099-1611(200005/06)9:3<183::AID-PON446>3.0.CO;2-L
Ahmad S, Fergus K, McCarthy M (2015) Psychosocial issues experienced by young women with breast cancer: the minority group with the majority of need. Curr Opin Support Palliat Care 9(3):271–278. https://doi.org/10.1097/SPC.0000000000000162
doi: 10.1097/SPC.0000000000000162 pubmed: 26147915
McClelland SI, Holland KJ, Griggs JJ (2015) Quality of life and metastatic breast cancer: the role of body image, disease site, and time since diagnosis. Qual Life Res 24(12):2939–2943. https://doi.org/10.1007/s11136-015-1034-3
doi: 10.1007/s11136-015-1034-3 pubmed: 26038224
Wortel RC, Alemayehu WG, Incrocci L (2015) Orchiectomy and radiotherapy for stage I–II testicular seminoma: a prospective evaluation of short-term effects on body image and sexual function. J Sex Med 12(1):210–218. https://doi.org/10.1111/jsm.12739
doi: 10.1111/jsm.12739 pubmed: 25370897
Rhondali W et al (2015) Screening for body image dissatisfaction in patients with advanced cancer: a pilot study. J Palliat Med 18(2):151–156. https://doi.org/10.1089/jpm.2013.0588
doi: 10.1089/jpm.2013.0588 pubmed: 25188590 pmcid: 4308823
Fauske L, Lorem G, Grov EK, Bondevik H (2016) Changes in the body image of bone sarcoma survivors following surgical treatment—a qualitative study. J Surg Oncol 113(2):229–234. https://doi.org/10.1002/jso.24138
doi: 10.1002/jso.24138 pubmed: 26714610
Harrington JM, Jones EG, Badger T (2009) Body image perceptions in men with prostate cancer. Oncol Nurs Forum 36(2):167–172. https://doi.org/10.1188/09.ONF.167-172
doi: 10.1188/09.ONF.167-172 pubmed: 19273405
Manier KK, Rowe LS, Welsh J, Armstrong TS (2018) The impact and incidence of altered body image in patients with head and neck tumors: a systematic review. Neuro-oncol Pract 5(4):204–213. https://doi.org/10.1093/nop/npy018
doi: 10.1093/nop/npy018
Cotrim H, Pereira G (2008) Impact of colorectal cancer on patient and family: implications for care. Eur J Oncol Nurs 12(3):217–226. https://doi.org/10.1016/j.ejon.2007.11.005
doi: 10.1016/j.ejon.2007.11.005 pubmed: 18567538
Rhoten BA, Murphy B, Ridner SH (2013) Body image in patients with head and neck cancer: A review of the literature. Oral Oncol 49(8):753–760. https://doi.org/10.1016/j.oraloncology.2013.04.005
doi: 10.1016/j.oraloncology.2013.04.005 pubmed: 23683468
Fingeret MC, Yuan Y, Urbauer D, Weston J, Nipomnick S, Weber R (2012) The nature and extent of body image concerns among surgically treated patients with head and neck cancer. Psychooncology 21(8):836–844. https://doi.org/10.1002/pon.1990
doi: 10.1002/pon.1990 pubmed: 21706673
Teo I et al (2016) Body image and quality of life of breast cancer patients: influence of timing and stage of breast reconstruction. Psychooncology 25(9):1106–1112. https://doi.org/10.1002/pon.3952
doi: 10.1002/pon.3952 pubmed: 26360810
Fingeret MC, Teo I, Epner DE (2014) Managing body image difficulties of adult cancer patients: lessons from available research. Cancer 120(5):633–641. https://doi.org/10.1002/cncr.28469
doi: 10.1002/cncr.28469 pubmed: 24895287
Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro-oncology 20(no. suppl_4):iv1–iv86. https://doi.org/10.1093/neuonc/noy131
doi: 10.1093/neuonc/noy131 pubmed: 6129949 pmcid: 6129949
Ostrom QT et al (2017) CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014. Neuro-Oncology 19(no. suppl_5):v1–v88. https://doi.org/10.1093/neuonc/nox158
doi: 10.1093/neuonc/nox158 pubmed: 29117289 pmcid: 5693142
Hopwood P, Fletcher I, Lee A, Al Ghazal S (2001) A body image scale for use with cancer patients. Eur J Cancer 37(2):189–197. https://doi.org/10.1016/S0959-8049(00)00353-1
doi: 10.1016/S0959-8049(00)00353-1 pubmed: 11166145
Hopwood P et al (2000) Clinical follow-up after bilateral risk reducing ('prophylactic’) mastectomy: mental health and body image outcomes. Psychooncology 9(6):462–472
doi: 10.1002/1099-1611(200011/12)9:6<462::AID-PON485>3.0.CO;2-J
Cash TF, Melnyk SE, Hrabosky JI (2004) The assessment of body image investment: an extensive revision of the appearance schemas inventory. Int J Eat Disord 35(3):305–316. https://doi.org/10.1002/eat.10264
doi: 10.1002/eat.10264 pubmed: 15048946
Armstrong TS et al (2006) Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT). J Neurooncol 80(1):27–35. https://doi.org/10.1007/s11060-006-9135-z
doi: 10.1007/s11060-006-9135-z pubmed: 16598415
Pilkonis PA, Yu L, Dodds NE, Johnston KL, Maihoefer CC, Lawrence SM (2014) Validation of the depression item bank from the Patient-Reported Outcomes Measurement Information System (PROMIS) in a three-month observational study. J Psychiatr Res 56:112–119. https://doi.org/10.1016/j.jpsychires.2014.05.010
doi: 10.1016/j.jpsychires.2014.05.010 pubmed: 24931848 pmcid: 4096965
Pilkonis PA, Choi SW, Reise SP, Stover AM, Riley WT, Cella D (2011) Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS(R)): depression, anxiety, and anger. Assessment 18(3):263–283. https://doi.org/10.1177/1073191111411667
doi: 10.1177/1073191111411667 pubmed: 21697139 pmcid: 3153635
Lai J-S, Garcia SF, Salsman JM, Rosenbloom S, Cella D (2012) The psychosocial impact of cancer: evidence in support of independent general positive and negative components. Qual Life Res 21(2):195–207. https://doi.org/10.1007/s11136-011-9935-2
doi: 10.1007/s11136-011-9935-2 pubmed: 21643875
IBM Corp. Released 2017. IBM SPSS Statistics for Windows, Version 25.0. IBM Corp, Armonk
Downing A et al (2019) Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study. Lancet Oncol 20(3):436–447. https://doi.org/10.1016/S1470-2045(18)30780-0
doi: 10.1016/S1470-2045(18)30780-0 pubmed: 30713036
Fingeret MC, Vidrine DJ, Reece GP, Gillenwater AM, Gritz ER (2010) Multidimensional analysis of body image concerns among newly diagnosed patients with oral cavity cancer. Head Neck 32(3):301–309. https://doi.org/10.1002/hed.21181
doi: 10.1002/hed.21181 pubmed: 19626634 pmcid: 2821979
Mosher CE, Johnson C, Dickler M, Norton L, Massie MJ, Duhamel K (2013) Living with metastatic breast cancer: a qualitative analysis of physical, psychological, and social sequelae. Breast J 19(3):285–292. https://doi.org/10.1111/tbj.12107
doi: 10.1111/tbj.12107 pubmed: 23528206 pmcid: 4097181
Pikler V, Winterowd C (2003) Racial and body image differences in coping for women diagnosed with breast cancer. Health Psychol 22(6):632–637. https://doi.org/10.1037/0278-6133.22.6.632
doi: 10.1037/0278-6133.22.6.632 pubmed: 14640861
Fobair P, Stewart SL, Chang S, D’Onofrio C, Banks PJ, Bloom JR (2006) Body image and sexual problems in young women with breast cancer. Psychooncology 15(7):579–594. https://doi.org/10.1002/pon.991
doi: 10.1002/pon.991 pubmed: 16287197
Dabeer M, Fingeret MC, Merchant F, Reece GP, Beahm EK, Markey MK (2008) Article commentary: a research agenda for appearance changes due to breast cancer treatment. Breast Cancer Basic Clin Res 2:BCBCR.S784. https://doi.org/10.4137/bcbcr.s784
doi: 10.4137/bcbcr.s784
Helgeson VS, Cohen S, Schulz R, Yasko J (1999) Education and peer discussion group interventions and adjustment to breast cancer. Arch Gen Psychiatry 56(4):340–347. https://doi.org/10.1001/archpsyc.56.4.340
doi: 10.1001/archpsyc.56.4.340 pubmed: 10197829
Colman MW et al (2015) Quality of life after en bloc resection of tumors in the mobile spine. Spine J 15(8):1728–1737. https://doi.org/10.1016/j.spinee.2015.03.042
doi: 10.1016/j.spinee.2015.03.042 pubmed: 25862510
Phukan R et al (2016) How does the level of sacral resection for primary malignant bone tumors affect physical and mental health, pain, mobility, incontinence, and sexual function? Clin Orthop Relat Res 474(3):687–696. https://doi.org/10.1007/s11999-015-4361-3
doi: 10.1007/s11999-015-4361-3 pubmed: 26013155
Armstrong TS et al (2010) Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module. J Neurosurg Spine 12(4):421–430. https://doi.org/10.3171/2009.10.SPINE0943
doi: 10.3171/2009.10.SPINE0943 pubmed: 20367379

Auteurs

Lindsay Rowe (L)

Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Lindsay.rowe@albertahealthservices.ca.

Elizabeth Vera (E)

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Alvina Acquaye (A)

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Sonja Crandon (S)

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Veeraj Shah (V)

University of Maryland, College Park, MD, USA.

Christine Bryla (C)

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Jing Wu (J)

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Kathleen Wall (K)

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Christine Siegel (C)

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Jennifer Reyes (J)

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Marta Penas-Prado (M)

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Nicole Leggiero (N)

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Christine Cordova (C)

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Eric Burton (E)

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Ramya Antony (R)

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Lisa Boris (L)

Leidos Biomedical Research, Frederick National Laboratory for Cancer Research Sponsored By the National Cancer Institute, Frederick, MD, USA.

Orwa Aboud (O)

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Yamini Vyas (Y)

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Peter Mathen (P)

Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Mark Gilbert (M)

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Kevin Camphausen (K)

Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Tito Mendoza (T)

Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Terri Armstrong (T)

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH